Please join GLG and Dr. Razmi in a three-part series as we discuss: The evolution of AI over the last century and its arrival as...

Please join GLG and Dr. Razmi in a three-part series as we discuss: The evolution of AI over the last century and its arrival as...

Please join GLG and Dr. Razmi in a three-part series as we discuss: The evolution of AI over the last century and its arrival as...

Distilled Post sits with Kinder’s Ron Razmi, to discuss the exciting 2021 SPAC market. There’s only one question on every savvy investor’s lips: Will 2021...

A top five pharmaceutical client was looking to boost their new lung cancer therapy, this is how we helped them achieve their goal. The problem:...

1:30 – 2:15 pm Sign in & Networking 2:15 – 2:30 pm Opening Remarks and Survey Results – W. Jerry Liu 2:30 – 3:45 pm...

For years, Big Pharma has marketed its drugs to healthcare providers using a tried-andtrue model: running clinical trials, publishing the results in journals, and presenting...

Mission impossible or mission unstoppable? Physicians are increasingly dissatisfied with just being clinicians and want to get involved in healthcare innovation. Similarly, innovative companies need...

  Kinders CEO, Dr. Razmi, will be attending the Cannes Film Festival in partnership with Golden Girls Productions in exhibiting and discussing the use of virtual...

    Kinders CEO, Dr. Razmi, will be a speaker at Medidata Next Executive Forum in New York City on May 16-17. He will speak about...